Skip to Main Content

Advertisement

American Association for Cancer Research Logo Open Menu
header search
Search
Advanced Search
Skip Nav Destination
photo of Elaine R. Mardis, PhD photo of Lillian L. Siu, MD

Editors-In-Chief


Elaine R. Mardis, PhD
Nationwide Children's Hospital
The Ohio State University

Lillian L. Siu, MD
Princess Margaret Cancer Centre
University of Toronto

SUBMIT TO JOURNAL EDITORS

Editors-In-Chief

Elaine R. Mardis, PhD
Nationwide Children's Hospital
The Ohio State University
    
Lillian L. Siu, MD
Princess Margaret Cancer Centre
University of Toronto
SUBMIT TO JOURNAL EDITORS

Editors' Corner

Editorial: Reflecting on Three Transformative Years of CRC

As we celebrate the third anniversary of Cancer Research Communications (CRC), we reflect on the remarkable journey we have undertaken since assuming the roles of co-Editors-in-Chief...(read more)
Editors’ Corner Archive

 

Journal Sections

Molecular and Cellular Biology
Loss of predicted cell adhesion molecule MPZL3 promotes EMT in ovarian cancer
Ya-Yun Cheng, Beth L. Worley et al.
Uncovering Novel lncRNAs Linked to Melanoma Growth and Migration with CRISPR Inhibition Screening
Stavroula Petroulia, Kathryn Hockemeyer et al.
The XPO1 inhibitor Eltanexor modulates the Wnt/β-catenin signaling pathway to reduce colorectal cancer tumorigenesis
Andrew E. Evans, Sahida Afroz et al.
Browse Section
Go to Section
Tumor Biology
Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid Tumors
Philippe A. Cassier, Mitesh J. Borad et al.
Loss of predicted cell adhesion molecule MPZL3 promotes EMT in ovarian cancer
Ya-Yun Cheng, Beth L. Worley et al.
Defining Non–small Cell Lung Cancer Tumor Microenvironment Changes at Primary and Acquired Immune Checkpoint Inhibitor Resistance Using Clinical and Real-World Data
Lang Ho Lee, Xin Xu et al.
Browse Section
Go to Section
Immuno-oncology
Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid Tumors
Philippe A. Cassier, Mitesh J. Borad et al.
Chemoimmunotherapy outcomes and prognostic factors in patients with advanced, low PD-L1-expressing non-small cell lung cancer
Tae Hata, Tadaaki Yamada et al.
Impact of Glucocorticoids on Immune Checkpoint Inhibitor Efficacy and Circulating Biomarkers in Non–Small Cell Lung Cancer Patients
Lauren Polyakov, Angelina Lim et al.
Browse Section
Go to Section
Emerging Technologies and Data Science
Modeling high-risk pediatric cancers in zebrafish to inform precision therapy
Nadine Azzam, Jamie I. Fletcher et al.
Uncovering Novel lncRNAs Linked to Melanoma Growth and Migration with CRISPR Inhibition Screening
Stavroula Petroulia, Kathryn Hockemeyer et al.
Protein-Level Analysis of Differential Response to Chemotherapy in Triple-Negative Breast Cancer Identifies CYP1B1 as a Biomarker for Chemotherapy Resistance
F. Scott Heinemann, Paul D. Gershon
Browse Section
Go to Section
Therapeutic Research and Development
Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid Tumors
Philippe A. Cassier, Mitesh J. Borad et al.
Chemoimmunotherapy outcomes and prognostic factors in patients with advanced, low PD-L1-expressing non-small cell lung cancer
Tae Hata, Tadaaki Yamada et al.
The XPO1 inhibitor Eltanexor modulates the Wnt/β-catenin signaling pathway to reduce colorectal cancer tumorigenesis
Andrew E. Evans, Sahida Afroz et al.
Browse Section
Go to Section
Precision Medicine and Biomarkers
Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid Tumors
Philippe A. Cassier, Mitesh J. Borad et al.
Plasma Cell-Free Human Papillomavirus (HPV) DNA and Oral Gargle HPV DNA in Patients with HPV-related Oropharyngeal Cancer Treated with Radiotherapy
Michelle Echevarria, Robin Park et al.
Modeling high-risk pediatric cancers in zebrafish to inform precision therapy
Nadine Azzam, Jamie I. Fletcher et al.
Browse Section
Go to Section
Clinical Research and Trials
Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid Tumors
Philippe A. Cassier, Mitesh J. Borad et al.
Plasma Cell-Free Human Papillomavirus (HPV) DNA and Oral Gargle HPV DNA in Patients with HPV-related Oropharyngeal Cancer Treated with Radiotherapy
Michelle Echevarria, Robin Park et al.
Impact of Glucocorticoids on Immune Checkpoint Inhibitor Efficacy and Circulating Biomarkers in Non–Small Cell Lung Cancer Patients
Lauren Polyakov, Angelina Lim et al.
Browse Section
Go to Section
Epidemiology and Prevention
Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women
Daniela Alves da Quinta, Darío Rocha et al.
The XPO1 inhibitor Eltanexor modulates the Wnt/β-catenin signaling pathway to reduce colorectal cancer tumorigenesis
Andrew E. Evans, Sahida Afroz et al.
Assessing racial disparities in guideline-concordant care and clinical outcomes after surgical resection of non-metastatic colon cancer at a comprehensive cancer center
Christina I. Lee, Sharafudeen D. Abubakar et al.
Browse Section
Go to Section
Health Disparities and Outcomes Research
Racial Disparities in Analgesic and Psychiatric Medication Use During End-Of-Life Care in Advanced-Stage Colorectal Cancer: A Retrospective Cohort Study
John M. Allen, Olga M. Trejos Kweyete et al.
Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women
Daniela Alves da Quinta, Darío Rocha et al.
Adiposity status close to diagnosis and its association with prostate cancer survival in the UK biobank
Margarita Cariolou, Sofia Christakoudi et al.
Browse Section
Go to Section
Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid Tumors
Plasma Cell-Free Human Papillomavirus (HPV) DNA and Oral Gargle HPV DNA in Patients with HPV-related Oropharyngeal Cancer Treated with Radiotherapy
Modeling high-risk pediatric cancers in zebrafish to inform precision therapy
Chemoimmunotherapy outcomes and prognostic factors in patients with advanced, low PD-L1-expressing non-small cell lung cancer
Uncovering Novel lncRNAs Linked to Melanoma Growth and Migration with CRISPR Inhibition Screening
  • Online ISSN 2767-9764

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal